NCT02216825View on ClinicalTrials.gov

Effect of L. Reuteri NCIMB 30242 on Plasma Bile Acid Profile

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

December 31, 2013

Study Completion Date

June 30, 2014

Conditions
Hypercholesterolemia
Interventions
DIETARY_SUPPLEMENT

Delayed release capsule, L. reuteri NCIMB 30242, escalated dose

DIETARY_SUPPLEMENT

Standard vegetarian capsule, L. reuteri NCIMB 30242, escalated dose

All Listed Sponsors
lead

Micropharma Limited

INDUSTRY

NCT02216825 - Effect of L. Reuteri NCIMB 30242 on Plasma Bile Acid Profile | Biotech Hunter | Biotech Hunter